Cargando…

Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study

Breast cancer-related lymphedema is a treatment-related chronic disease that causes great distress and medical burden. Early screening and precautionary measures for lymphedema could improve well-being and decrease medical costs. Herein, we used bioelectrical impedance analysis for early screening o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Linli, Chen, Huaying, Zheng, Xuemei, Wu, Shaoyong, Yu, Youhui, Lan, Lu, Xu, Liang, Xu, Jumei, Fan, Hongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484636/
https://www.ncbi.nlm.nih.gov/pubmed/36121834
http://dx.doi.org/10.1371/journal.pone.0274570
_version_ 1784791914303717376
author Zhuang, Linli
Chen, Huaying
Zheng, Xuemei
Wu, Shaoyong
Yu, Youhui
Lan, Lu
Xu, Liang
Xu, Jumei
Fan, Hongying
author_facet Zhuang, Linli
Chen, Huaying
Zheng, Xuemei
Wu, Shaoyong
Yu, Youhui
Lan, Lu
Xu, Liang
Xu, Jumei
Fan, Hongying
author_sort Zhuang, Linli
collection PubMed
description Breast cancer-related lymphedema is a treatment-related chronic disease that causes great distress and medical burden. Early screening and precautionary measures for lymphedema could improve well-being and decrease medical costs. Herein, we used bioelectrical impedance analysis for early screening of lymphedema. We set up a verifiable standardized subclinical standard to screen subclinical lymphedema in postoperative breast cancer patients using bioelectrical impedance. The first part determined the criteria of subclinical lymphedema. Among the 424 female participants, 127 were healthy women, whereas 297 were postoperative breast cancer survivors. Subclinical standard boundaries were determined by the 95% confidence interval of the healthy women. The screening rate of patients with subclinical lymphedema was inferred by comparing the subclinical standard boundaries and the postoperative patient values. A total of 14.81–20.87% of postoperative breast cancer survivors were identified as patients with subclinical lymphedema. The second part provided the results of the verification test of this subclinical standard. The data of the verification test from 30 healthy women and 30 screened patients met the subclinical standard, and 30 breast cancer survivors with lymphedema verified the utility and feasibility of the subclinical standard. Therefore, this standard could provide a screening tool for early the identification of subclinical breast cancer survivors. Early detection helps implement personal and precise medical precautions for patients with subclinical lymphedema.
format Online
Article
Text
id pubmed-9484636
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-94846362022-09-20 Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study Zhuang, Linli Chen, Huaying Zheng, Xuemei Wu, Shaoyong Yu, Youhui Lan, Lu Xu, Liang Xu, Jumei Fan, Hongying PLoS One Research Article Breast cancer-related lymphedema is a treatment-related chronic disease that causes great distress and medical burden. Early screening and precautionary measures for lymphedema could improve well-being and decrease medical costs. Herein, we used bioelectrical impedance analysis for early screening of lymphedema. We set up a verifiable standardized subclinical standard to screen subclinical lymphedema in postoperative breast cancer patients using bioelectrical impedance. The first part determined the criteria of subclinical lymphedema. Among the 424 female participants, 127 were healthy women, whereas 297 were postoperative breast cancer survivors. Subclinical standard boundaries were determined by the 95% confidence interval of the healthy women. The screening rate of patients with subclinical lymphedema was inferred by comparing the subclinical standard boundaries and the postoperative patient values. A total of 14.81–20.87% of postoperative breast cancer survivors were identified as patients with subclinical lymphedema. The second part provided the results of the verification test of this subclinical standard. The data of the verification test from 30 healthy women and 30 screened patients met the subclinical standard, and 30 breast cancer survivors with lymphedema verified the utility and feasibility of the subclinical standard. Therefore, this standard could provide a screening tool for early the identification of subclinical breast cancer survivors. Early detection helps implement personal and precise medical precautions for patients with subclinical lymphedema. Public Library of Science 2022-09-19 /pmc/articles/PMC9484636/ /pubmed/36121834 http://dx.doi.org/10.1371/journal.pone.0274570 Text en © 2022 Zhuang et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Zhuang, Linli
Chen, Huaying
Zheng, Xuemei
Wu, Shaoyong
Yu, Youhui
Lan, Lu
Xu, Liang
Xu, Jumei
Fan, Hongying
Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study
title Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study
title_full Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study
title_fullStr Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study
title_full_unstemmed Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study
title_short Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study
title_sort bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: a case–control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484636/
https://www.ncbi.nlm.nih.gov/pubmed/36121834
http://dx.doi.org/10.1371/journal.pone.0274570
work_keys_str_mv AT zhuanglinli bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT chenhuaying bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT zhengxuemei bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT wushaoyong bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT yuyouhui bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT lanlu bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT xuliang bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT xujumei bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy
AT fanhongying bioelectricalimpedanceanalysisforearlyscreeningofupperlimbsubclinicallymphedemaacasecontrolstudy